Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Urol. Jul 24, 2014; 3(2): 54-65
Published online Jul 24, 2014. doi: 10.5410/wjcu.v3.i2.54
Laparoendoscopic single site, laparoscopic or open surgery for adrenal tumors: Selecting the optimal approach
Christopher B Riedinger, Conrad M Tobert, Brian R Lane
Christopher B Riedinger, Conrad M Tobert, Brian R Lane, Michigan State University College of Human Medicine, Grand Rapids, MI 49503, United States
Brian R Lane, Urology Division, Spectrum Health Hospital System, Grand Rapids, MI 49503, United States
Author contributions: Riedinger CB, Tobert CM and Lane BR solely contributed to this paper.
Correspondence to: Brian R Lane, MD, PhD, FACS, Chief Betz Family Endowed Chair for Cancer Research, Urology Division, Spectrum Health Hospital System, 4069 Lake Drive SE, Suite 313, Grand Rapids, MI 49503, United States. brian.lane@spectrumhealth.org
Telephone: +1-616-2677333 Fax: +1-616-2678040
Received: December 5, 2013
Revised: March 7, 2014
Accepted: April 3, 2014
Published online: July 24, 2014
Processing time: 226 Days and 9.3 Hours
Core Tip

Core tip: Minimally-invasive adrenalectomy remains the surgical treatment of choice for most adrenal lesions. Tumor size and stage are the primary indications for selecting alternative treatment modalities. Open surgical adrenalectomy remains the gold standard for large tumors (> 10 cm) and suspected or known advanced stage malignancy. laparoendoscopic single-site adrenalectomy appears to be an appropriate initial approach for small tumors (< 4-5 cm), including pheochromocytoma and isolated adrenal metastases.